Search results
Results From The WOW.Com Content Network
SYNLAB sold its veterinary diagnostics segment to Mars Incorporated in 2023. Corporate structure. Mathieu Floreani is the CEO of SYNLAB Group, who changed from DHL to SYNLAB in 2018. The former CEO and co-founder of SYNLAB, Bartl Wimmer, retired from this position at the end of March 2018.
Synnovis. Synnovis, formerly Viapath, is a London-based provider of pathology services. It is a partnership between Guy's and St Thomas' NHS Foundation Trust, King's College Hospital NHS Foundation Trust, and SYNLAB UK & Ireland. [1]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Alma mater. University of Pennsylvania. University of Edinburgh. Occupation. Business Executive. Known for. CEO, Williams-Sonoma, Inc. Laura J. Alber (born 1968) [1] is an American businesswoman who in 2010 became the CEO of Williams-Sonoma, Inc. [2]
Executive chairman and president of MicroStrategy [1] Michael J. Saylor (born February 4, 1965) is an American entrepreneur and business executive. He is the executive chairman and co-founder of MicroStrategy, a company that provides business intelligence, mobile software, and cloud-based services. Saylor was MicroStrategy's chief executive ...
Judith Faulkner. Judith R. Faulkner (born August 11, 1943) is an American billionaire businesswoman who is the CEO and founder of Epic Systems, a healthcare software company located in Verona, Wisconsin. [2] Faulkner founded Epic Systems in 1979, with the original name of Human Services Computing. [3] In 2013, Forbes called her "the most ...
Wilson’s age, 58, plus his short tenure in the CEO role, and the form and language of the notice all contributed to the score, Exechange researcher Daniel Schauber wrote in the firm’s April ...
Albert Bourla. October 21, 1961) is an American-Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla was chief operating officer .